PF and especially FMDs, because of their periodic use, limited burden on human subjects, and effects on IGF-1, insulin, glucose, IGFBP-1 and ketone bodies levels, have the potential for applications in cancer prevention and treatment [10,133,134,135]. The gene discussed is IGF1; the disease is cancer.